Posted by MediSmart Advisors on
The Inflation Reduction Act of 2022 encompasses various measures aimed at decreasing the expenses of prescription medications for individuals enrolled in Medicare by introducing a ceiling on the amount beneficiaries will pay out of their own pockets for drugs covered by Medicare Part D plans. Additionally, it aims to curtail the amount spent by the federal government on pharmaceuticals. These actions involve modifications to the Medicare Part D drug benefit program.
Click here to read this article.